Basics |
West Pharmaceutical Services, Inc.
West Pharmaceutical Services Inc develops, manufactures and sells packaging components and systems for injectable drug delivery, including stoppers and seals for vials, closures and other components used in syringe, and prefillable syringe components.
|
IPO Date: |
January 2, 1990 |
Sector: |
Healthcare |
Industry: |
Health Care Equipment and Supplies |
Market Cap: |
$15.16B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$1.43 | 1.15%
|
Avg Daily Range (30 D): |
$2.63 | 1.23%
|
Avg Daily Range (90 D): |
$3.90 | 1.69%
|
Institutional Daily Volume |
Avg Daily Volume: |
.26M |
Avg Daily Volume (30 D): |
.63M |
Avg Daily Volume (90 D): |
.78M |
Trade Size |
Avg Trade Size (Sh.): |
62 |
Avg Trade Size (Sh.) (30 D): |
35 |
Avg Trade Size (Sh.) (90 D): |
36 |
Institutional Trades |
Total Inst.Trades: |
7,198 |
Avg Inst. Trade: |
$8.11M |
Avg Inst. Trade (30 D): |
$15.27M |
Avg Inst. Trade (90 D): |
$16.12M |
Avg Inst. Trade Volume: |
.05M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$12.17M |
Avg Closing Trade (30 D): |
$28.45M |
Avg Closing Trade (90 D): |
$32.2M |
Avg Closing Volume: |
59.39K |
|
|
|
|
News |
Jun 1, 2025 @ 12:48 PM
ROSEN, LEADING INVESTOR COUNSEL, Encourages West P...
Source: N/A
|
May 30, 2025 @ 5:45 PM
DEADLINE ALERT for WST, DMRC, CODI, ELV: Law Offic...
Source: Law Offices Of Howard G. Smith
|
May 29, 2025 @ 9:57 PM
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Wes...
Source: N/A
|
May 27, 2025 @ 4:00 PM
Deadline Alert: West Pharmaceutical Services, Inc....
Source: N/A
|
May 26, 2025 @ 8:07 PM
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages ...
Source: N/A
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$6.42
|
$1.24
|
$1.79
|
Diluted EPS
|
$6.37
|
$1.23
|
$1.78
|
Revenue
|
$ 2.9B
|
$ 698M
|
$ 748.8M
|
Gross Profit
|
$ 1B
|
$ 231.9M
|
$ 273.6M
|
Net Income / Loss
|
$ 467.2M
|
$ 89.8M
|
$ 130.1M
|
Operating Income / Loss
|
$ 554.1M
|
$ 107M
|
$ 159.6M
|
Cost of Revenue
|
$ 1.9B
|
$ 466.1M
|
$ 475.2M
|
Net Cash Flow
|
$ -197.6M
|
$ -80.4M
|
$ -6.3M
|
PE Ratio
|
32.81
|
|
|
Splits |
Sep 27, 2013:
2:1
|
Sep 30, 2004:
2:1
|
|